Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04974775 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Swecrit Biobank - Blood Samples From Critically Ill Patients and Healthy Controls

Study acronym: SWECRIT
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study completion date: Dec 31, 2024 to Dec 31, 2026v4
  2. Re-verified, no change to tracked fieldsv3
  3. Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Jun 2024 to Dec 31, 2024
    • Site details revised at 4 of 4 sites
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Blood samples are collected and stored in a biobank for later analysis of circulating substances in peripheral blood and genetic variations in patients with severe critical illness and risk of death. The aim is to analyze stored samples in order to identify substances that can help predict the outcome of critically ill patients, but also to optimize treatment and possibly prevent serious illness and death in the future.
Trial Details
NCT Number NCT04974775
Lead Sponsor Skane University Hospital
Collaborators: Region Skane, Lund University
Conditions
(from sponsor)		 Critical Illness, Cardiac Arrest, Sepsis, Influenza, Covid19, Trauma
Related terms COVID-19, Critical Illness, Heart Arrest, Influenza, Human, Sepsis, Wounds and Injuries
Enrollment 8,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov